← All organizations
Highest phase reached
Phase 2
First clinical trial
Dec 1, 2005Last known activity
Mar 13, 2025
Timeline
1990s
- Jun 1, 1998
Enanta Pharmaceuticals— Founded
Drugs by trial phase (27 distinct, 43 trials)
Phase 2 (6 own, 0 via acquisition)
Phase 1 (21 own, 0 via acquisition)
Indications
Studied for
- Cholangitis
- Communicable Diseases
- Fatty Liver
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis C
- Herpesviridae Infections
- Infections
- Liver Cirrhosis
- Liver Cirrhosis, Biliary
- Non-alcoholic Fatty Liver Disease
- Pneumonia
- Respiratory Syncytial Virus Infections
- Respiratory Tract Infections
- Soft Tissue Infections
- Virus Diseases
Recent trials (50)
- NCT06917508OfficialPhase 1Mar 13, 2025
- NCT06917508Lead sponsorPhase 1Mar 13, 2025
- NCT06847464OfficialPhase 1Jan 27, 2025
- NCT06847464Lead sponsorPhase 1Jan 27, 2025
- NCT06601192Lead sponsorPhase 1Jul 15, 2024
- NCT06601192OfficialPhase 1Jul 15, 2024
- NCT06170242Lead sponsorPhase 2Nov 20, 2023
- NCT06170242Study directorPhase 2Nov 20, 2023
- NCT05568706Study directorPhase 2Nov 29, 2022
- NCT05568706Lead sponsorPhase 2Nov 29, 2022
- NCT05616728Study directorPhase 2Nov 10, 2022
- NCT05616728Lead sponsorPhase 2Nov 10, 2022
- NCT05594602Lead sponsorPhase 1Oct 31, 2022
- NCT05594602Study directorPhase 1Oct 31, 2022
- NCT05594615Study directorPhase 1Oct 6, 2022
Details
- Founded
- Watertown, MA, US Jun 1, 1998
- Last known activity
- Mar 13, 2025